UK Pharmacies Warn Middle East Tensions Could Disrupt Essential Medicine Supplies
Essential Medicines Face Supply Risks Amid Middle East Shipping Disruptions
LONDON: (News Desk) – Pharmacies across the United Kingdom have warned that escalating tensions in the Middle East and uncertainty surrounding shipping through the Strait of Hormuz are disrupting medicine supply chains, raising concerns about potential shortages of essential drugs.
According to the British Independent Pharmacy Association (BIPA), stocks of several critical medicines have fallen to alarmingly low levels, putting pressure on the availability of certain treatments.
The association said the UK imports approximately three-quarters of its medicines from overseas, making its pharmaceutical supply chain vulnerable to international disruptions. It warned that the Middle East conflict and uncertainty over transport routes through the Strait of Hormuz had added further pressure to supplies.
BIPA also highlighted concerns over the production of medicines imported from the European Union, noting that their manufacturing often depends on raw materials sourced from countries such as China and India.
Disruptions to international supply chains could therefore affect the continued availability of several medicines, the association warned.
The drugs identified as being at risk of shortages include treatments for high blood pressure, pain relief medicines used by cancer patients and certain cholesterol-lowering medications.

Comments are closed, but trackbacks and pingbacks are open.